Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

July 6, 2022

July 2022: Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis

Loading ...

Diagnostic yield, optimal timing, and methodology of next generation sequencing data reanalysis.

Next generation sequencing has becoming increasingly powerful in diagnosing Mendelian disorders, yet typically more than 50 percent of cases remain unsolved after an initial clinical exome or clinical genome sequencing. So a team of researchers set out to review the literature to attempt to answer the question: Is it worth reanalyzing unsolved cases, and if so, when should such a reanalysis take place to reap the most possible benefit? Tri Phan, PhD, professor of medicine at the Garvan Institute and the University of New South Wales in Sydney, joins this month’s GenePod to discuss the results of the research.

July 2022: Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis

Related articles